Wegovy Day 4: What Your Body Is Doing and What's Normal

Nausea typically peaks around days 3–5 of the first Wegovy dose — day 4 sits squarely inside that window for many people.
Semaglutide reaches its highest blood concentration roughly 24–48 hours after injection, meaning symptom intensity often tracks that curve.
Reduced appetite at this stage is the medicine working as intended, not a sign something is wrong.
Symptoms that feel severe, include sharp stomach pain, or don't ease after the first week deserve a conversation with a prescriber or GP.

By day 4 of your first Wegovy dose, most people are somewhere in the middle of the early adjustment window — past the novelty of the first injection, but not yet at the relative calm that tends to follow by the end of week one. Nausea is common at this point, often peaking around days 3 to 5, and tiredness or a quieter appetite may feel more noticeable than they did on day one. This is semaglutide settling into your system: it reaches its peak blood concentration roughly 24 to 48 hours after each injection, so day 4 often catches people at or just past that peak. These medicines are prescription-only and every patient's response is different, which is why a prescriber reviews your case before treatment starts and remains involved as you progress.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A Day-by-Day Picture of the Wegovy Adjustment Period

Step 1, The 24 to 72-hour mark: what happened before day 4

Understanding day 4 is easier once you know what preceded it. After your first 0.25 mg subcutaneous injection, semaglutide is absorbed gradually and reaches peak plasma levels at around the 24-to-48-hour point. That means the highest concentration in your system lands on days 2 or 3 for most people.

Days 1 through 3 bring a range of reactions: some people feel little at all, others notice nausea, mild headache, or an early drop in appetite as soon as the following morning. You can read a more detailed breakdown in our Wegovy day-by-day guide if you want the full arc in one place, or dip into the day one overview to compare how your first 24 hours measured up against what's typical. If you want to look at individual days in more detail, our guide to what happens on day 2 of Wegovy and the closer look at day 3 of Wegovy walk through each stage as the drug's concentration builds.

The reason early doses start low (0.25 mg is a tolerability dose, its job is to let your system adjust, not to drive the main weight-loss effect) is precisely to soften this initial peak. Even so, day 3 or 4 is when many people notice nausea or fatigue more sharply than they expected. That's not unusual, and it tends to ease.

Step 2, Day 4 specifically: the symptoms, the logic, and the red lines

Nausea is the most reported symptom at this stage, followed by fatigue, loose stools or constipation, and sometimes a dull headache. The NHS patient information on semaglutide lists nausea, diarrhoea, vomiting and constipation as the most common early effects, they appear in this pattern across the clinical programme and generally settle within days to a couple of weeks.

Appetite suppression tends to feel clearest around now. GLP-1 receptor agonists slow gastric emptying and signal satiety; the practical result is that food feels less appealing and smaller amounts fill you up. That's the medicine doing exactly what it's designed to do, not your body being deprived of something it needs.

The red lines are different. Seek medical help promptly if you experience severe, persistent stomach pain that radiates toward your back (with or without vomiting) as this can be a sign of acute pancreatitis, which the MHRA flagged as an infrequent but potentially serious effect in a January 2026 Drug Safety Update. Signs of dehydration (intense thirst, no urine output, dizziness on standing) from persistent vomiting also need prompt attention. Anything in that category: call 111 or attend your nearest urgent treatment centre.

Everything else (mild nausea, a dodgy appetite, feeling a bit flat) fits the normal picture at day 4.

Step 3, Practical things that help right now

Small, bland meals eaten slowly tend to reduce nausea far better than skipping food entirely. Protein first helps preserve muscle mass on a reduced intake; staying well hydrated matters more than usual when your appetite is down. Avoid rich, fatty or very spicy food for the first week. Ginger (in any form) has a reasonable evidence base for nausea management and won't interfere with semaglutide.

On the timing front: if you injected on a Monday and you're reading this on Thursday, you're right in the thick of day 4. Some people choose to time their first injection around a quieter few days at home (a long weekend or a week away from heavier commitments) so that if nausea does land, it lands at a manageable moment. Worth thinking about before your next dose if this week has been harder than you anticipated.

Keep the pen refrigerated at 2–8°C when you're not using it; always check the Patient Information Leaflet for the exact storage and handling instructions rather than relying on memory or online summaries. The semaglutide information page covers the mechanism and clinical background in more detail if you'd like to understand why the titration schedule is built the way it is.

Step 4, Looking ahead from day 4

Day 5 through 7 tends to bring a gradual easing of early GI symptoms for most people, though not everyone follows that curve on schedule. By the end of week one the body has begun adapting to the new baseline, and the second injection (due at the start of week two) introduces a repeat of the same 0.25 mg dose rather than an increase. Titration is a slow, deliberate process for good reason.

The longer picture on Wegovy is well-documented: the STEP 1 trial, published in the New England Journal of Medicine, recorded an average of around 15% body-weight reduction over 68 weeks at the 2.4 mg maintenance dose. Day 4 is a long way from 2.4 mg, but knowing the destination helps make the start of the journey feel more purposeful.

If you're considering starting Wegovy and haven't yet had a clinical assessment, our weight-loss treatment consultation page explains the process. Questions about eligibility, your medical history, or whether to continue after a rough few days are exactly the kind of thing a prescriber should hear. The Wegovy overview covers the licensed indications and how the treatment pathway works, and the FAQs address a number of the most common day-to-day concerns. If you'd like to speak to someone directly, the contact page connects you with our aftercare team, seven days a week. You can also read more about how we approach clinical oversight on the about us page.

Day 4 is rarely anyone's favourite day on Wegovy. It passes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions